Military Health System

Cardiac Conditions

• Identification #: N/A
• Date: 4/10/2003
• Type: Memorandums
• Topics: Smallpox (ACAM2000)

William Winkenwerder, Jr., M.D.

William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), provided written testimony on Fighting Fraud: Improving Information Security in front of a joint hearing of the House Committee on Financial Services Subcommittee on Financial Institutions and the Subcommittee on Oversight and Investigations.

Tom Carrato

Mr. Carrato, Chief Operating Officer and Deputy Assistant Secretary of Defense for Health Plan Administration, testified on Purchasing Health Care in a Competitive Environment in front of the Senate Finance Committee. Mr. Carrato testified on behalf of William Winkenwerder, Jr., MD.

Policy for Requirements Associated with the Food and Drug Administration Approval of Pyridostigmine Bromide Tablets as a Nerve Agent Pretreatment

• Identification #: 03-011
• Date: 3/27/2003
• Type: Memorandums
• Topics: N/A

William Winkenwerder, Jr. M.D.

William Winkenwerder, Jr. MD, Assistant Secretary of Defense (Health Affairs), testified on defense heath and matters relating to DoD budget request for FY 2004 before the House Armed Services Committee Subcommittee on Total Force.

William Winkenwerder, Jr., M.D.

William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified on the status of implementation of Public Law 107-287, the Department of Veterans Affairs Emergency Preparedness Act of 2002; and VA-DOD efforts to coordinate force protection in the active duty military forces of the United States for those Service men and women who may be exposed to chemical, biological, or radiological weapons of mass destruction in theaters of conflict, before the House Committee on Veterans’ Affairs Subcommittee on Health.

Administering Smallpox Vaccine

• Identification #: N/A
• Date: 3/25/2003
• Type: Directives
• Topics: Smallpox (ACAM2000)

William Winkenwerder, Jr., M.D.

William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified on protecting the health of deployed forces and lessons learned from the Persian Gulf War, before the House Committee on Government Reform Subcommittee on National Security, Emerging Threats and International Relations.

DoD Instruction: Armed Forces Institute of Pathology

Implements policy, assigns responsibilities, and prescribes procedures for the administration and management of the Armed Forces Institute of Pathology (AFIP)

• Identification #: N/A
• Date: 3/18/2003
• Type: Instructions
• Topics: N/A

Clarification of Service Responsibilities in Vaccinating DoD Personnel and Dependents Assigned to to DoS Missions or Residing in High-Threat Areas

• Identification #: N/A
• Date: 3/13/2003
• Type: Memorandums
• Topics: Anthrax

NAVADMIN SMALLPOX VACCINATION PROGRAM AUTHORIZATION TO VACCINATE

NAVADMIN SMALLPOX VACCINATION PROGRAM (SVP) AUTHORIZATION TO VACCINATE

• Identification #: N/A
• Date: 3/12/2003
• Type: Directives
• Topics: Smallpox (ACAM2000)

Dr. David S. C. Chu and William Winkenwerder, Jr., M.D.

Dr. David S. C. Chu, Under Secretary of Defense (Personnel and Readiness) and William Winkenwerder, Jr., MD, Assistant Secretary of Defense (Health Affairs), testified before the Senate Armed Services Committee Subcommittee on Military Personnel.

TRICARE Benefits for Activated Reserve Component Personnel and Families

• Identification #: 03-004
• Date: 3/10/2003
• Type: Memorandums
• Topics: N/A

P&T Meeting - March 2003

Minutes for the DoD P&T Committee Meeting from March 2003

P&T Executive Council - March 2003

Minutes for the DoD P&T Executive Committee Meeting from March 2003